160 related articles for article (PubMed ID: 15233670)
1. The cost-effectiveness of hepatic venous pressure gradient monitoring in the prevention of recurrent variceal hemorrhage.
Targownik LE; Spiegel BM; Dulai GS; Karsan HA; Gralnek IM
Am J Gastroenterol; 2004 Jul; 99(7):1306-15. PubMed ID: 15233670
[TBL] [Abstract][Full Text] [Related]
2. Endoscopic screening for esophageal varices in cirrhosis: Is it ever cost effective?
Spiegel BM; Targownik L; Dulai GS; Karsan HA; Gralnek IM
Hepatology; 2003 Feb; 37(2):366-77. PubMed ID: 12540787
[TBL] [Abstract][Full Text] [Related]
3. Costs and clinical outcomes of primary prophylaxis of variceal bleeding in patients with hepatic cirrhosis: a decision analytic model.
Saab S; DeRosa V; Nieto J; Durazo F; Han S; Roth B
Am J Gastroenterol; 2003 Apr; 98(4):763-70. PubMed ID: 12738453
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic cyanoacrylate injection versus beta-blocker for secondary prophylaxis of gastric variceal bleed: a randomised controlled trial.
Mishra SR; Chander Sharma B; Kumar A; Sarin SK
Gut; 2010 Jun; 59(6):729-35. PubMed ID: 20551457
[TBL] [Abstract][Full Text] [Related]
5. Measuring the hemodynamic response to primary pharmacoprophylaxis of variceal bleeding: a cost-effectiveness analysis.
Imperiale TF; Chalasani N; Klein RW
Am J Gastroenterol; 2003 Dec; 98(12):2742-50. PubMed ID: 14687827
[TBL] [Abstract][Full Text] [Related]
6. A cost-utility analysis of secondary prophylaxis for variceal hemorrhage.
Rubenstein JH; Eisen GM; Inadomi JM
Am J Gastroenterol; 2004 Jul; 99(7):1274-88. PubMed ID: 15233665
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic therapy for the prevention of recurrent esophageal variceal bleeding.
Russo MW; Zacks SL; Sandler RS; Brown RS
Hepatology; 2000 Feb; 31(2):358-63. PubMed ID: 10655258
[TBL] [Abstract][Full Text] [Related]
8. [A cost-effectiveness study of hepatic venous pressure gradient measurement in the secondary prevention of variceal bleeding].
Amorós A; Palazón JM; Zapater P; de Madaria E; Pérez-Mateo M
Rev Esp Enferm Dig; 2008 Jul; 100(7):416-22. PubMed ID: 18808289
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic band ligation in the treatment of portal hypertension.
Garcia-Pagán JC; Bosch J
Nat Clin Pract Gastroenterol Hepatol; 2005 Nov; 2(11):526-35. PubMed ID: 16355158
[TBL] [Abstract][Full Text] [Related]
10. Preventing first variceal hemorrhage in cirrhosis.
Albillos A
J Clin Gastroenterol; 2007; 41 Suppl 3():S305-11. PubMed ID: 17975481
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of variceal ligation vs. beta-blockers for primary prevention of variceal bleeding.
Imperiale TF; Klein RW; Chalasani N
Hepatology; 2007 Apr; 45(4):870-8. PubMed ID: 17393528
[TBL] [Abstract][Full Text] [Related]
12. Sustained rise of portal pressure after sclerotherapy, but not band ligation, in acute variceal bleeding in cirrhosis.
Avgerinos A; Armonis A; Stefanidis G; Mathou N; Vlachogiannakos J; Kougioumtzian A; Triantos C; Papaxoinis C; Manolakopoulos S; Panani A; Raptis SA
Hepatology; 2004 Jun; 39(6):1623-30. PubMed ID: 15185303
[TBL] [Abstract][Full Text] [Related]
13. Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy.
Abraldes JG; Villanueva C; Bañares R; Aracil C; Catalina MV; Garci A-Pagán JC; Bosch J;
J Hepatol; 2008 Feb; 48(2):229-36. PubMed ID: 18093686
[TBL] [Abstract][Full Text] [Related]
14. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol.
Reiberger T; Ulbrich G; Ferlitsch A; Payer BA; Schwabl P; Pinter M; Heinisch BB; Trauner M; Kramer L; Peck-Radosavljevic M;
Gut; 2013 Nov; 62(11):1634-41. PubMed ID: 23250049
[TBL] [Abstract][Full Text] [Related]
15. The budget impact of endoscopic screening for esophageal varices in cirrhosis.
Spiegel BM; Esrailian E; Eisen G
Gastrointest Endosc; 2007 Oct; 66(4):679-92. PubMed ID: 17905009
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic response-guided therapy for prevention of variceal rebleeding: an uncontrolled pilot study.
González A; Augustin S; Pérez M; Dot J; Saperas E; Tomasello A; Segarra A; Armengol JR; Malagelada JR; Esteban R; Guardia J; Genescà J
Hepatology; 2006 Oct; 44(4):806-12. PubMed ID: 17006916
[TBL] [Abstract][Full Text] [Related]
17. Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: a multicentre randomised controlled trial.
García-Pagán JC; Villanueva C; Albillos A; Bañares R; Morillas R; Abraldes JG; Bosch J;
Gut; 2009 Aug; 58(8):1144-50. PubMed ID: 19218249
[TBL] [Abstract][Full Text] [Related]
18. Value of the hepatic venous pressure gradient to monitor drug therapy for portal hypertension: a meta-analysis.
Albillos A; Bañares R; González M; Ripoll C; Gonzalez R; Catalina MV; Molinero LM
Am J Gastroenterol; 2007 May; 102(5):1116-26. PubMed ID: 17391317
[TBL] [Abstract][Full Text] [Related]
19. Factors predicting success of endoscopic variceal ligation for secondary prophylaxis of esophageal variceal bleeding.
Harewood GC; Baron TH; Song LM
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):237-41. PubMed ID: 16460480
[TBL] [Abstract][Full Text] [Related]
20. Prevention of variceal rebleeding.
Bosch J; García-Pagán JC
Lancet; 2003 Mar; 361(9361):952-4. PubMed ID: 12648985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
